拜耳拜瑞妥在中国上市了吗？

The original research of rivaroxaban was jointly developed by Bayer/Johnson & Johnson, and the Bayer Group originated in Germany. Bayer is headquartered in Leverkusen, Germany, a town on the east bank of the Rhine River between Cologne and Dusseldorf. The Bayer Group is a leading international company in the chemical and pharmaceutical industry. In addition to operating more than 10,000 products produced by itself, its business scope includes medicine, diagnostic equipment, crop protection products, plastics and fibers, etc. Is Bayer's Xarelto available in China?

Bayer's Xarelto has been on the market in China since 2009. It is mainly used clinically to prevent the formation of deep vein thrombosis (DVT) and pulmonary embolism (ChemicalbookPE) in patients after hip and knee replacement surgery. It can also be used to prevent stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation, and reduce the risk of recurrence of coronary syndrome.

Xarelto can be said to be an ideal anticoagulant. A randomized, double-blind, active drug-controlled international multi-center phase III clinical study (RECORD) involving 12,500 patients from 39 countries proved that Xarelto is significantly more effective in preventing venous thrombosis after total hip or total knee replacement than enoxaparin injection. The relative risk of symptomatic venous thrombosis and all-cause death after two weeks of use is 56% lower than that of enoxaparin, and the safety is equivalent to the latter.

In addition to Xarelto, which is marketed in China, the original drug is also on the market in Turkey. The price is relatively cheap, benefiting more ordinary family patients. Patients who want to know more about the Turkish version of Xarelto drugs can contact Medical Travel Service. Medical Travel is an overseas medical service company. Medical Travel cooperates with foreign pharmaceutical companies to provide patients with regular drug purchase channels.

Recommended related hot articles: /newsDetail/92143.html